Oral Disease-Modifying Therapies for Multiple Sclerosis

Classical multiple sclerosis (MS) treatments using first-line injectable drugs, although widely applied, remain a major concern in terms of therapeutic adherence and efficacy. New oral drugs recently approved for MS treatment represent significant advances in therapy. The oral route of administratio...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Woojun, Zandoná, Manuella Edler, Kim, Su-Hyun, Kim, Ho Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neurological Association 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302185/
https://www.ncbi.nlm.nih.gov/pubmed/25628732
http://dx.doi.org/10.3988/jcn.2015.11.1.9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302185/
https://www.ncbi.nlm.nih.gov/pubmed/25628732
http://dx.doi.org/10.3988/jcn.2015.11.1.9

Ejemplares similares